liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
ECT in Parkinson's disease - dopamine transporter visualised by [I-123]-beta-CIT SPECT
Linköping University, Faculty of Health Sciences. Linköping University, Department of Clinical and Experimental Medicine, Geriatric . Östergötlands Läns Landsting, Local Health Care Services in Central Östergötland, Department of Geriatric Medicine.
Linköping University, Faculty of Health Sciences. Linköping University, Department of Medicine and Health Sciences, Radiation Physics . Östergötlands Läns Landsting, Centre of Surgery and Oncology, Department of Radiation Physics.
Linköping University, Faculty of Health Sciences. Linköping University, Department of Clinical and Experimental Medicine, Geriatric . Östergötlands Läns Landsting, Local Health Care Services in Central Östergötland, Department of Geriatric Medicine.
Linköping University, Faculty of Health Sciences. Linköping University, Department of Medicine and Health Sciences, Clinical Physiology . Östergötlands Läns Landsting, Heart Centre, Department of Clinical Physiology.
2000 (English)In: Journal of neural transmission, ISSN 0300-9564, Vol. 107, no 8-9, 997-1008 p.Article in journal (Refereed) Published
Abstract [en]

Parkinson's disease (PD) is characterised by a loss of dopaminergic neurones in the basal ganglia. These neurones may be visualised by single photon emission computed tomography (SPECT) with the cocaine analogue 2 beta-carboxymethyl-3-beta-(4-iodophenyl)tropane ([(123)]beta-CIT), which labels the dopamine reuptake sites in the nerve terminals. In order to evaluate the possibility to predict the outcome of ECT a prospective study was performed with six PD patients in whom the [I-123]beta-CIT uptake was measured before and after an electroconvulsive therapy (ECT) series. The side-to-side difference in the radiotracer uptake was found to be significantly lower in striatum located contralaterally to the part of the body with the most pronounced symptomathology. No significant change in uptake of the radioligand was seen after ECT. Patients with best uptake and thus with less advanced PD improved most after ECT. The possibility to use the [I-123]beta-CIT uptake to predict the outcome of ECT treatment has to be further evaluated.

Place, publisher, year, edition, pages
2000. Vol. 107, no 8-9, 997-1008 p.
Keyword [en]
Parkinson's disease, electroconvulsive therapy, single photon emission computerized tomography (SPECT), [I-123]beta-CIT
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-49623OAI: oai:DiVA.org:liu-49623DiVA: diva2:270519
Available from: 2009-10-11 Created: 2009-10-11 Last updated: 2011-01-14

Open Access in DiVA

No full text

Authority records BETA

Fall, Per-ArneEkberg, StefanGranerus, Ann-KathrineGranerus, Göran

Search in DiVA

By author/editor
Fall, Per-ArneEkberg, StefanGranerus, Ann-KathrineGranerus, Göran
By organisation
Faculty of Health SciencesGeriatric Department of Geriatric MedicineRadiation Physics Department of Radiation PhysicsClinical Physiology Department of Clinical Physiology
In the same journal
Journal of neural transmission
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 76 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf